Cargando…

Brimonidine Ophthalmic Solution 0.025% for Reduction of Ocular Redness: A Randomized Clinical Trial

SIGNIFICANCE: The α(2)-adrenergic receptor agonist brimonidine has been reported to induce conjunctival blanching in cataract, strabismus, laser refractive, and filtration procedures. Clinicians are often faced with red eyes with no apparent underlying pathology. Low-dose brimonidine reduced ocular...

Descripción completa

Detalles Bibliográficos
Autores principales:	McLaurin, Eugene, Cavet, Megan E., Gomes, Paul J., Ciolino, Joseph B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Original Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839712/ https://www.ncbi.nlm.nih.gov/pubmed/29461408 http://dx.doi.org/10.1097/OPX.0000000000001182

Ejemplares similares

Effect of over-the-counter brimonidine tartrate 0.025% ophthalmic solution on pupil size in healthy adults
por: Nejad, Mitra, et al.
Publicado: (2021)

Low‐dose brimonidine for relief of ocular redness: integrated analysis of four clinical trials
por: Ackerman, Stacey L, et al.
Publicado: (2018)

Dynamic Mechanical Properties and Microstructure of an (Al(0.5)CoCrFeNi)(0.95)Mo(0.025)C(0.025) High Entropy Alloy
por: Wang, Bingfeng, et al.
Publicado: (2019)

Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials
por: McLaurin, Eugene B., et al.
Publicado: (2014)

Comparison of efficacy and safety of topical 1% nadifloxacin and tretinoin 0.025% combination therapy with 1% clindamycin and tretinoin 0.025% combination therapy in patients of mild-to-moderate acne
por: Deshmukh, Swapnil Narayan, et al.
Publicado: (2018)

Cryochemically Processed Li(1+y)Mn(1.95)Ni(0.025)Co(0.025)O(4) (y = 0, 0.1) Cathode Materials for Li-Ion Batteries
por: Normakhmedov, Ofok O., et al.
Publicado: (2018)

Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials
por: Ciolino, Joseph B, et al.
Publicado: (2015)

Experimental study of loop shape using 0.025-inch ERCP guidewires (with videos)
por: Ogura, Takeshi, et al.
Publicado: (2021)

Lotilaner Ophthalmic Solution 0.25%: First Approval
por: Syed, Yahiya Y.
Publicado: (2023)

Steerable-wire technique using high-flow steerable microcatheter and 0.025-inch guidewire
por: Maruyama, Mitsunari, et al.
Publicado: (2023)

Critical phenomena and estimation of the spontaneous magnetization from a mean field analysis of the magnetic entropy change in La(0.7)Ca(0.1)Pb(0.2)Mn(0.95)Al(0.025)Sn(0.025)O(3)
por: Dhahri, Khadija, et al.
Publicado: (2018)

Correction to: Lotilaner Ophthalmic Solution 0.25%: First Approval
por: Syed, Yahiya Y.
Publicado: (2023)

Effects of brimonidine tartrate 0.1% ophthalmic solution on the pupil, refraction, and light reflex
por: Kato, C. O. Sayaka, et al.
Publicado: (2018)

Effects of brimonidine tartrate 0.2 and 0.15% ophthalmic solution on the static and dynamic pupil characteristics
por: Yang, Jing, et al.
Publicado: (2023)

Effect of Solution pH on Distribution of Ophthalmically Administered Brimonidine in Posterior Ocular Tissues in Pigmented Rabbits
por: Shinno, Keisuke, et al.
Publicado: (2019)

Impact of guidewire caliber on ERCP outcomes: Systematic review and meta-analysis comparing 0.025- and 0.035-inch guidewires
por: Aziz, Muhammad, et al.
Publicado: (2022)

Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study
por: Orii, Yusuke, et al.
Publicado: (2023)

Efficacy and safety of fluocinolone acetonide 0.025% otic solution in patients with otic eczema: a randomized, double-blind, placebo-controlled clinical trial
por: Montoro, Victoria, et al.
Publicado: (2018)

Clinical utility of 0.025-inch guidewire VisiGlide2(TM) in the endoscopic retrograde cholangiopancreatography-related procedures
por: Sakai, Yuji, et al.
Publicado: (2017)

The feasibility of pancreatic duct stenting using a novel 4-Fr plastic stent with a 0.025-in. guidewire
por: Nagai, Kazumasa, et al.
Publicado: (2021)

Intravitreal Injection of 1.25% Povidone Iodine Followed by Vitrectomy Using 0.025% Povidone Iodine Irrigation for Treating Endophthalmitis
por: Nakashizuka, Hiroyuki, et al.
Publicado: (2019)

Pilot Equivalence Study Comparing Different Batches of Topical 0.025% Capsaicin Emulsion: Product Microstructure, Release, and Permeation Evaluation
por: Navarro-Pujol, Francesc, et al.
Publicado: (2021)

Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis
por: Chigbu, DeGaulle I, et al.
Publicado: (2015)

Rheological Properties, Dissolution Kinetics, and Ocular Pharmacokinetics of Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38%
por: Cavet, Megan E., et al.
Publicado: (2019)

Brimonidine and timolol concentrations in the human vitreous and aqueous humors after topical instillation of a 0.1% brimonidine tartrate and 0.5% timolol fixed-combination ophthalmic solution: An interventional study
por: Orii, Yusuke, et al.
Publicado: (2022)

Vitrectomy using 0.025% povidone-iodine irrigation for treating post-traumatic endophthalmitis due to intraocular foreign bodies: Two case reports
por: Liu, Chi, et al.
Publicado: (2023)

Exploring hydrothermal liquefaction (HTL) of digested sewage sludge (DSS) at 5.3 L and 0.025 L bench scale using experimental design
por: Hegdahl, Stian Hersvik, et al.
Publicado: (2023)

Brimonidine in the treatment of glaucoma and ocular hypertension
por: Cantor, Louis B
Publicado: (2006)

The Efficacy and Safety of 17α-Estradiol (Ell-Cranell® alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study
por: Kim, Jae-Hong, et al.
Publicado: (2012)

Dose Uniformity of Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38% Compared with Prednisolone Acetate Ophthalmic Suspension 1%
por: Marlowe, Zora T., et al.
Publicado: (2021)

Safety and Efficacy of Topical Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: A Pilot Study
por: Gonzalez-Salinas, Roberto, et al.
Publicado: (2021)

Large magnetic entropy change and prediction of magnetoresistance using a magnetic field in La(0.5)Sm(0.1)Sr(0.4)Mn(0.975)In(0.025)O(3)
por: Dhahri, M., et al.
Publicado: (2018)

Ropivacaine 0.025% mixed with fentanyl 3.0 μg/ml and epinephrine 0.5 μg/ml is effective for epidural patient-controlled analgesia after cesarean section
por: Cohen, Shaul, et al.
Publicado: (2015)

Effects of Composition Variations on the Crystalline Phases and Photoluminescence Properties of Ca(2+x)MgSi(2)Eu(0.025)O(7+x) Phosphors
por: Tseng, Hsien-Wei, et al.
Publicado: (2022)

The chemotactic properties of various topical brimonidine tartrate ophthalmic preparations
por: Alonso, Ruiz Simonato, et al.
Publicado: (2020)

Efficacy and Safety of Novel Formulation of Clobetasol Propionate 0.025% Cream in Indian Moderate-to-Severe Psoriasis Patients: Phase-2a, Randomized 3-Arm Study
por: Sidgiddi, Srinivas, et al.
Publicado: (2021)

Bepotastine besilate ophthalmic solution 1.5% for alleviating nasal symptoms in patients with allergic conjunctivitis
por: Cavet, Megan E, et al.
Publicado: (2018)

Comparison of timolol 0.5% + brimonidine 0.2% + dorzolamide 2% versus timolol 0.5% + brimonidine 0.2% in a Mexican population with primary open-angle glaucoma or ocular hypertension
por: Baiza-Durán, Leopoldo Martín, et al.
Publicado: (2012)

Controllable Doping of Mn into Ni(0.075‐x)Mn(x)Al(0.025)(OH)(2)(CO(3))(0.0125)·yH(2)O for Efficient Adsorption of Fluoride Ions
por: Wagassa, Ararso N., et al.
Publicado: (2023)

Randomized Trial of Brinzolamide/Brimonidine Versus Brinzolamide Plus Brimonidine for Open-Angle Glaucoma or Ocular Hypertension
por: Gandolfi, Stefano A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_neoccrlgsc8r2csm4tkpnc2i0m